Sort
30,917 grants matching “tumor microenvironment”
Identifying novel therapies targeting Merkel cell carcinoma and tumor microenvironment
$379,343Ling Gao · Southern California Inst For Res/Educ · R01 · FY2023 · CA
Novel Approaches to Targeting Cancers Associated with VHL Mutations
$379,337Ramaprasad Srinivasan · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Chemical Exchange Saturation Transfer (CEST) MRI for the Characterization Small Renal Masses
$379,324Elena Vinogradov · Ut Southwestern Medical Center · R01 · FY2025 · CA
A Novel Symbiotic Approach for Ovarian Cancer
$379,248Jogender Tushir-Singh · University Of California At Davis · R01 · FY2022 · CA
Cell Control via Spatiotemporal Microenvironmental pH Modulation
$379,245Jinglei Ping · University Of Massachusetts Amherst · R35 · FY2023 · GM
NSAIDs During Postpartum Involution for Breast Cancer Chemoprevention
$379,238Pepper J Schedin · Oregon Health & Science University · R01 · FY2022 · CA
Identification of USP13 as a therapeutic target for ovarian cancer
$379,129Xiongbin Lu · Indiana University Indianapolis · R01 · FY2018 · CA
Stromal metabolism promotes therapeutic resistance in pancreatic cancer
$379,104Costas Andreas Lyssiotis · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
Optimization and validation of integrated microscale technologies for low-cost, automated production of PET molecular imaging tracers for cancer research
$379,082Robert Michael Van Dam · University Of California Los Angeles · R33 · FY2019 · CA
Optimization and validation of integrated microscale technologies for low-cost, automated production of PET molecular imaging tracers for cancer research
$379,082Robert Michael Van Dam · University Of California Los Angeles · R33 · FY2020 · CA
Optimization and validation of integrated microscale technologies for low-cost, automated production of PET molecular imaging tracers for cancer research
$379,082Robert Michael Van Dam · University Of California Los Angeles · R33 · FY2021 · CA
E3 ligase mediated control of Foxp3 expression and immune suppression-mechanisms and potential as immunotherapeutic target
$379,055Drew M. Pardoll · Johns Hopkins University · R01 · FY2022 · AI
The B7x pathways in the tumor microenvironment
$379,050Xingxing Zang · Albert Einstein College Of Medicine · R01 · FY2024 · CA
Roles of microbiota-mediated hepatocarcinogenesis
$379,043Xin Wei Wang · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Epigenetic regulation of pancreatic cancer subtype identity and tumorigenesis by PHF2
$378,947Andrew Liss · Massachusetts General Hospital · R01 · FY2025 · CA
Epigenetic regulation of pancreatic cancer subtype identity and tumorigenesis by PHF2
$378,947Andrew Liss · Massachusetts General Hospital · R01 · FY2023 · CA
Regulation of lung cancer metastasis through transcriptional control of the Golgi apparatus
$378,946Jonathan M Kurie · University Of Tx Md Anderson Can Ctr · R01 · FY2017 · CA
Targeting Metabolic Liabilities in Cancer
$378,938Richard Lewis Possemato · New York University School Of Medicine · R01 · FY2019 · CA
Targeting CCR2-expressing myeloid cells to overcome immune checkpoint inhibitor resistance in glioma
$378,934Jeffrey K Harrison · University Of Florida · R01 · FY2019 · NS
Targeting CCR2-expressing myeloid cells to overcome immune checkpoint inhibitor resistance in glioma
$378,934Jeffrey K Harrison · University Of Florida · R01 · FY2020 · NS
Targeting CCR2-expressing myeloid cells to overcome immune checkpoint inhibitor resistance in glioma
$378,934Jeffrey K Harrison · University Of Florida · R01 · FY2021 · NS
Targeting CCR2-expressing myeloid cells to overcome immune checkpoint inhibitor resistance in glioma
$378,934Jeffrey K Harrison · University Of Florida · R01 · FY2022 · NS
Amyloid-bodies and the Evolution of Malignancies
$378,919Stephen Lee · University Of Miami School Of Medicine · R01 · FY2024 · CA
Impact of extracellular glutathione catabolism on triple-negative breast cancer
$378,863Isaac Spencer Harris · University Of Rochester · R01 · FY2025 · CA
Colorectal carcinogenesis and Fusobacterium nucleatum: oncomicrobe, oncometabolites, and oncoimmunology
$378,813Wendy S. Garrett · Harvard School Of Public Health · R01 · FY2023 · CA